Cosmos Health Inc. (NASDAQ:COSM – Get Free Report) CEO Grigorios Siokas bought 354,296 shares of Cosmos Health stock in a transaction on Monday, February 24th. The shares were purchased at an average cost of $0.56 per share, for a total transaction of $198,405.76. Following the acquisition, the chief executive officer now owns 3,897,016 shares in the company, valued at $2,182,328.96. The trade was a 10.00 % increase in their ownership of the stock. The purchase was disclosed in a document filed with the SEC, which can be accessed through this hyperlink.
Grigorios Siokas also recently made the following trade(s):
- On Thursday, January 30th, Grigorios Siokas bought 51,414 shares of Cosmos Health stock. The shares were purchased at an average cost of $0.66 per share, for a total transaction of $33,933.24.
- On Wednesday, January 22nd, Grigorios Siokas bought 38,900 shares of Cosmos Health stock. The shares were purchased at an average cost of $0.77 per share, for a total transaction of $29,953.00.
- On Friday, January 17th, Grigorios Siokas bought 29,158 shares of Cosmos Health stock. The shares were purchased at an average cost of $0.86 per share, for a total transaction of $25,075.88.
- On Wednesday, January 15th, Grigorios Siokas purchased 62,500 shares of Cosmos Health stock. The shares were bought at an average price of $0.80 per share, for a total transaction of $50,000.00.
- On Monday, January 13th, Grigorios Siokas purchased 163,666 shares of Cosmos Health stock. The shares were bought at an average price of $0.61 per share, for a total transaction of $99,836.26.
- On Friday, December 20th, Grigorios Siokas purchased 257,334 shares of Cosmos Health stock. The shares were bought at an average price of $0.58 per share, for a total transaction of $149,253.72.
Cosmos Health Stock Up 4.5 %
Shares of Cosmos Health stock opened at $0.59 on Wednesday. The company has a current ratio of 1.44, a quick ratio of 1.24 and a debt-to-equity ratio of 0.08. The business’s 50 day simple moving average is $0.69 and its 200-day simple moving average is $0.82. The stock has a market capitalization of $13.72 million, a price-to-earnings ratio of -0.24 and a beta of 5.56. Cosmos Health Inc. has a twelve month low of $0.47 and a twelve month high of $1.58.
Institutional Trading of Cosmos Health
Cosmos Health Company Profile
Cosmos Health Inc manufactures, develops, and trades branded nutraceutical products in Greece, the United Kingdom, Croatia, Bulgaria, Cayman Islands, and Cyprus. It offers medicines, OTC medicines, nutraceutical products, vitamins, minerals and dietary, health care products, medical devices, baby products, and others under the Sky Premium Life and Mediterranation brand names.
Featured Stories
- Five stocks we like better than Cosmos Health
- How to Capture the Benefits of Dividend Increases
- Nebius Slides Post-Earnings: A Long-Term Buy Opportunity?
- Growth Stocks: What They Are, Examples and How to Invest
- NVIDIA Stock: A Market Barometer in Tech’s Turbulent Times
- 2 Rising CRM Platform Stocks That Can Surge Higher in 2025
- Palantir Stock Nears Bear Market Territory – Why and What’s Next?
Receive News & Ratings for Cosmos Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cosmos Health and related companies with MarketBeat.com's FREE daily email newsletter.